Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
All cases were derived from patients on a phase II study of everolimus performed at Memorial Sloan-Kettering Cancer Center (ClinicalTrials.gov number NCT00805129). Patients were analyzed for which adequate tumor and normal tissue was available for sequencing. DNA was extracted from tumor tissue and from peripheral blood or adjacent normal urothelial tissue.
Item
All cases were derived from patients on a phase II study of everolimus performed at Memorial Sloan-Kettering Cancer Center (ClinicalTrials.gov number NCT00805129). Patients were analyzed for which adequate tumor and normal tissue was available for sequencing. DNA was extracted from tumor tissue and from peripheral blood or adjacent normal urothelial tissue.
boolean
C1706256 (UMLS CUI [1,1])
C0282460 (UMLS CUI [1,2])
C0541315 (UMLS CUI [1,3])
C1513120 (UMLS CUI [1,4])
C0475358 (UMLS CUI [2,1])
C3640076 (UMLS CUI [2,2])
C0040300 (UMLS CUI [2,3])
C3839098 (UMLS CUI [3,1])
C0475358 (UMLS CUI [3,2])
C0229664 (UMLS CUI [3,3])
C0205307 (UMLS CUI [3,4])
C0227598 (UMLS CUI [3,5])